After four impactful years of collaboration, the RECOGNISED project, funded by the EU’s Horizon 2020 programme, has successfully reached its conclusion. This initiative brought together 21 partners from nine countries, including academic institutions, small and medium enterprises (SMEs), patient advocacy groups, and international research infrastructures like EATRIS, showcasing the power of multidisciplinary collaboration. Learn more about RECOGNISED project at [link]
Key Achievements:
🔬 Innovative Research: The project explored the use of the retina as a “window to the brain,” focusing on how retinal changes can serve as biomarkers for cognitive decline and dementia in individuals with type 2 diabetes.
đź’ˇ Groundbreaking Findings: Researchers conducted experimental and clinical studies, uncovering common molecular mechanisms between diabetic retinopathy and Alzheimer’s disease.
🌍 Global Collaboration: With partners from across Europe, including Montenegro, Spain, Italy, the UK, and the Netherlands, the project fostered a diverse network of experts in diabetes, ophthalmology, and neurology.
The insights gained through RECOGNISED have opened new avenues for early detection and treatment strategies, improving the quality of life for people with type 2 diabetes at risk of cognitive decline.
We extend our gratitude to all the partners and researchers for their dedication and to the European Union for their support through Horizon 2020.
Together, we are advancing the future of healthcare. đź’™